Imamura H., Furukawa H., Kishimoto T., Miyazaki Y., Yamamoto K., Nakae S., Inoue K., Tsukahara Y., Imamoto M., Yamazaki K., Okano S., Morimoto S., Sugihara S., Shimokawa T.: Muticenter Phase II Study of 2 Weeks Administration with TS-1 Followed by 1 Week Rest against Metastatic Gastric Cancer. The 7th International Conference of Asian Clinical Oncology Society, Beijing, China.